Table 1.
Demographic and biochemical characteristics of subjects included in the study
| Variables | Studied Groups | P value | |
| Hepatitis C patients (n=87) Mean ± SD |
Control (n=25) Mean ± SD |
||
| Age | 40.62 ± 8.56 | 35.20 ± 7.35 | 0.05 |
| Sex | |||
| Males % | 52 (59.8%) | 15 (60%) | 0.3 |
| Females % | 35 (40.2%) | 10 (40%) | |
| ALT (U/L) | 87.8±58.2 | 36±8.0 | P=0.0001* |
| AST (U/L) | 107±65.8 | 33.8±7.5 | P=0.0001* |
| Total Bilirubin (mg/dl) | 1.43±0.79 | 0.83±0.3 | P=0.0001* |
| Direct Bilirubin (mg/dl) | 0.46±0.28 | 0.19±0.08 | P=0.0001* |
| Alkaline phosphatase (U/L) | 123.5±53.4 | 48.7±8.6 | P=0.0001* |
| Albumin (g/l) | 3.29±0.45 | 3.93±0.53 | P=0.0001* |
| Alfa fetoprotein (ng/ml) | 14.2±8.3 | 4.7±1.8 | P=0.0001* |
| Prothrombin time (seconds) | 13.5±1.7 | 10.1±0.4 | P=0.0001* |
| Osteopontin protein (ng/ml) | 35.21±4.3 | 24.3±8.8 | P=0.0001* |
Indicate a statistical significant difference